Cytodyn Inc (CYDY)

[jakeflies]

Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species

Published: March 31, 2022
https://doi.org/10.1371/journal.ppat.1010396

https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1010396&fbclid=IwAR3glwpuI-yAnhy319F27fipAOcop1GfLspkJU8x3uqawKk2N6yGZMu2VsY

"Our results demonstrate that weekly, self-administered Leronlimab was safe, well-tolerated, and efficacious for long-term virologic suppression and should be included in the arsenal of safe, easily administered, longer-acting antiretroviral treatments for people living with HIV-1."